Go Pro

Agios Pharmaceuticals (AGIO) Stock Forecast & Price Target

Agios Pharmaceuticals logo
$33.32 -0.96 (-2.80%)
As of 08/28/2026 04:00 PM Eastern

Agios Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
1
Hold
4
Buy
6

Based on 11 Wall Street analysts who have issued ratings for Agios Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 11 analysts, 1 has given a sell rating, 4 have given a hold rating, 5 have given a buy rating, and 1 has given a strong buy rating for AGIO.

Consensus Price Target

$41.25
23.80% Upside
According to the 11 analysts' twelve-month price targets for Agios Pharmaceuticals, the average price target is $41.25. The highest price target for AGIO is $55.00, while the lowest price target for AGIO is $32.00. The average price target represents a forecasted upside of 23.80% from the current price of $33.32.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for AGIO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AGIO Analyst Ratings Over Time

TypeCurrent Forecast
8/29/25 to 8/29/26
1 Month Ago
7/30/25 to 7/30/26
3 Months Ago
5/31/25 to 5/31/26
1 Year Ago
8/29/24 to 8/29/25
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
4 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$41.25$40.00$41.44$56.33
Forecasted Upside23.80% Upside22.14% Upside40.97% Upside49.39% Upside
Consensus RatingModerate BuyHoldHoldModerate Buy

AGIO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

AGIO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Agios Pharmaceuticals Stock vs. The Competition

TypeAgios PharmaceuticalsHealthcare CompaniesBroader Market
Consensus Rating Score
2.55
2.30
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside23.80% Upside841.59% Upside13.05% Upside
News Sentiment Rating
Positive News

See Recent AGIO News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
8/24/2026
TD Cowen logo
TD Cowen
3 of 5 stars
 UpgradeStrong-Buy
8/7/2026
Tessa Romero
Tessa Romero
5 of 5 stars
Boost TargetNeutral$31.00 ➝ $34.00+7.12%
7/31/2026
Citigroup Inc. logo
Citigroup
4 of 5 stars
Samantha Semenkow
5 of 5 stars
Boost TargetBuy$46.00 ➝ $52.00+58.78%
7/31/2026Lower TargetBuy$41.00 ➝ $39.00+19.08%
7/30/2026Boost TargetBuy$52.00 ➝ $55.00+66.56%
7/7/2026Boost TargetSector Perform$28.00 ➝ $32.00-14.42%
7/7/2026Boost TargetBuy$40.00 ➝ $46.00+23.03%
6/24/2026 Reiterated RatingSell (D)
4/1/2026Boost TargetNeutral$28.00 ➝ $32.00-6.91%
12/26/2025Boost TargetOutperform$34.00 ➝ $40.00+38.41%
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

11/4/2025 UpgradeStrong SellHold
7/28/2025Lower TargetSector Outperform$71.00 ➝ $65.00+74.73%
12/18/2024 Reiterated RatingOverweight
10/10/2024Reiterated RatingOutperform$51.00+24.39%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 11:41 PM ET.


AGIO Forecast - Frequently Asked Questions

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Agios Pharmaceuticals is $41.25, with a high forecast of $55.00 and a low forecast of $32.00.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agios Pharmaceuticals in the last year. There is currently 1 sell rating, 4 hold ratings, 5 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AGIO shares.

According to analysts, Agios Pharmaceuticals's stock has a predicted upside of 23.80% based on their 12-month stock forecasts.

Over the previous 90 days, Agios Pharmaceuticals's stock had 1 upgrade by analysts.

Agios Pharmaceuticals has been rated by research analysts at Bank of America, Citigroup, HC Wainwright, JPMorgan Chase & Co., Royal Bank Of Canada, TD Cowen, Truist Financial, and Weiss Ratings in the past 90 days.

Analysts like Agios Pharmaceuticals more than other "healthcare" companies. The consensus rating for Agios Pharmaceuticals is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how AGIO compares to other companies.


MarketBeat monitors more than a dozen sources for Agios Pharmaceuticals analyst ratings, with the most recent rating issued on 8/24/2026.
From Our Partners